NH Investment & Securities
VC Fund
Seoul, South Korea
NH Investment & Securities is a VC fund in Seoul focused on Biotechnology and Health Care. NH Investment & Securities engages in wealth management, investment banking, trading, and equity sales businesses in South Korea and internationally. It operates through Sales, Investment Bank, and Trading segments. The Sales segment offers asset management services, such as brokerage consignment, financial instrument sales, etc. toindividuals, and domestic or foreign institutional investors. The Investment Bank segment provides corporate finance services, including corporate finance, M&A, PF, PEF operation, etc. The Trading segment is involved in stocks and bonds operations, product operations, the supply of derivatives, and capital investment activities. Woori Investment & Securities that began operation in 1969 became NH Investment & Securities in December 2014, with its headquarters in Seoul in South Korea.
- Total investments:
- 93
- Last investment:
- Lead investor:
- 19%
Last updated:
For AI agents: llms.txt
Industries NH Investment & Securities invests in
Stages NH Investment & Securities invests in
Countries NH Investment & Securities invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Round size
- Series A
- $2.6M–$22M
- Series B
- $2.8M–$54M
- Series C
- $9.6M–$46M
Investment Focus
Industry
- Biotechnology 17 (18%)
- Health Care 14 (15%)
- Software 12 (13%)
- Medical 10 (11%)
- Pharmaceutical 10 (11%)
Stage
- Series B 21 (23%)
- Series A 20 (22%)
- Series C 16 (17%)
- Venture - Series Unknown 9 (10%)
- Seed 6 (6%)
Country
- South Korea 75 (81%)
- United States 3 (3%)
- India 1 (1%)
- Spain 1 (1%)
- Indonesia 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Jeong Young-Chae
President & Chief Executive Officer
|
President & Chief Executive Officer | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
We are creating ‘hyper-automated insurance platforms’ to comprehensively support underwriters and claim adjusters and to facilitate communication between insurers and reinsurers using AI and deep learning. | $22M / Series A / Jul 02, 2026 | |
|
|
Perseus's hypervisor technology and security solution simplifies and secures automobile infrastructure.A standard ARM SoC found in the automotive industry can only support one operating system, and connected cars typically carry 120 SoCs, but we can reduce that to 30 with our solution, saving up to 75% on average, and of course with asimpler ecosystem, it’s easier to secure. With Perseus hypervisor, we are able to run multiple applications or operating systems off of a single SoC, which helps to reduce the in-car system complexity. Our technology is able to offer a fine grained on/off rate control and flexible and real-time control security parameters. Our security parameters can be pre-programmed, controlled algorithmically, or just manually recorded to requirement. Also, we’re able to offer a 100% performance guarantee of systems that we secure even under an OS attack. | $10.5M / Series B / Jun 10, 2026 | |
|
|
WIRobotics is a Wearable robot that lessen physical demands on your body to safely allow active motion. | $63.5M / Series B / May 15, 2026 | |
|
|
Korean Air provides passenger air transportation, air cargo logistics, and related travel services through scheduled and charter flight operations. The company transports passengers between international and domestic destinations and manages ticketing, reservations, and in-flight services through its digital platforms and airport operations. Itscargo division handles freight transportation, including general cargo, special shipments, and charter logistics, and supports shipment tracking and electronic air waybill processing. The company also operates integrated logistics services such as trucking connections that link air routes with ground transport networks for cargo delivery. In addition, Korean Air runs programs that allow cargo customers to measure and reduce transportation-related carbon emissions through the use of sustainable aviation fuel initiatives. | $40.4M / Debt Financing / Apr 10, 2026 | |
|
|
Estech Pharma is a raw material pharmaceutical company. | $6.7M / Convertible Note / Mar 19, 2026 | |
|
|
ROKIT Healthcare provides hardware, software, and application support. Their custom fabrication technologies deliver solutions to the design, creation, and applications of three-dimensional systems. They provide suffering patients and humans with a hyper-personalized medical organ regeneration solution. They apply artificial intelligence and 3dbioprinting technology to regenerate the skin and cartilage organs through surgery for patients. | $42.5M / Post-IPO Equity / Mar 10, 2026 | |
|
|
Clush is an AI and cloud infrastructure company that builds enterprise software to help organizations develop, deploy, and manage AI systems. The company offers cloud-native services and products, enabling customers to build, manage, and collaborate on cloud-based applications and data. Clush provides products such as Clush Kube MLOps, AIgovernance platforms, AI agents, hybrid cloud infrastructure, and enterprise collaboration tools for industries including finance, manufacturing, and public sector organizations | $26.3M / Venture - Series Unknown / Jan 27, 2026 | |
|
|
SDT is an IoT platform company that specializes in product design, hardware engineering, and cloud service. | $20.5M / Venture - Series Unknown / Jan 12, 2026 | |
|
|
Dasan Pharmaceutical is a pharmaceutical CDMO (contract development and manufacturing organization). | $8.8M / Venture - Series Unknown / Dec 23, 2025 | |
|
|
ENCell is a biotech company that develops and manufactures biopharmaceuticals. | $15.3M / Post-IPO Debt / Dec 04, 2025 | |
| See all 93 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does NH Investment & Securities invest in?
NH Investment & Securities invests primarily in Biotechnology, Health Care and Software startups, most often at Series B and Series A stage. Most of the 93 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is NH Investment & Securities's check size?
NH Investment & Securities typically joins rounds of $2.6M–$22M at Series A, $2.8M–$54M at Series B and $9.6M–$46M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds NH Investment & Securities participates in.
How do I contact NH Investment & Securities?
Public channels for NH Investment & Securities include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at NH Investment & Securities?
The team at NH Investment & Securities includes Jeong Young-Chae (President & Chief Executive Officer). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!